News about Global Pharma

Avanos Medical Appoints Indrani Franchini to Board of Directors

Franchini served as Executive Vice President and Chief Legal Officer at Alnylam Pharmaceuticals. From June 2017 to July 2021, she served as Executive Vice President and Chief Compliance Officer at Alexion Pharmaceuticals, Inc., where she led a comprehensive transformation of the company's compliance program.

Global Pharma | 01/07/2024 | By Manvi |  213

TruDiagnostic Introduces Organ-Specific Aging Analysis from SYMPHONYAge Algorithms

TruDiagnostic has developed epigenetic aging analysis of individual organ systems, using validated and system-specific trained clocks.

Global Pharma | 01/07/2024 | By Aishwarya |  1704

AbbVie Announces Acquisition of Celsius Therapeutics

AbbVie has acquired Celsius Therapeutics, Inc., a privately held biotechnology company pioneering new therapies for patients with inflammatory disease.

Global Pharma | 29/06/2024 | By Aishwarya |  979

Emcure Plans for Expansion and New Acquisitions with Upcoming IPO

Emcure Pharmaceuticals has been planning to expand its business as the upcoming initial public offering (IPO) will give the company access to new growth capital which it will use to fund inorganic growth and explore acquisitions.

Global Pharma | 29/06/2024 | By Aishwarya |  1810

Orchid Pharma and Cipla to Launch Cefepime-Enmetazobactam in India

Orchid Pharma has launched its new drug, Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract infections (cUTI), Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) indications.

Global Pharma | 29/06/2024 | By Aishwarya |  1068

Formation Bio Bags USD 372 MM in Series D Funding

Formation Bio has raised USD 372 MM of Series D financing.

Global Pharma | 28/06/2024 | By Aishwarya |  727

CASI Pharmaceuticals Plans to Submit IND Application For CID-103

CASI Pharmaceuticals, Inc. has planned to submit an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for CID-103 for the treatment of antibody-mediated rejection (AMR) in kidney transplant recipients by the end of 2024.

Global Pharma | 28/06/2024 | By Aishwarya |  734

Cellares Signs Deal with Kite to Evaluate Its Cell Shuttle Automated Manufacturing Platform

Cellares has announced that Kite will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle.

Global Pharma | 28/06/2024 | By Aishwarya |  638

Glenmark and IADVL Raise Awareness Campaign to Support Vitiligo Patients in India

Glenmark Pharmaceuticals Ltd. has joined forces with The Indian Association of Dermatologists, Venereologists, and Leprologists (IADVL), to unveil postcards & Calendars aimed at raising awareness.

Global Pharma | 28/06/2024 | By Aishwarya |  794

Verona Pharma Secures US FDA Approval of Ohtuvayre

Verona Pharma has announced that the US Food and Drug Administration (FDA) approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.

Global Pharma | 27/06/2024 | By Aishwarya |  1145